1. NOD1 deficiency ameliorates the progression of diabetic retinopathy by modulating bone marrow-retina crosstalk.
- Author
-
Qiu J, Wu J, Chen W, Ruan Y, Mao J, Li S, Tang X, Zhao L, Li S, Li K, Liu D, and Duan Y
- Subjects
- Animals, Mice, Bone Marrow metabolism, Hematopoietic Stem Cells metabolism, Inflammation genetics, Inflammation metabolism, Mice, Inbred C57BL, Retina metabolism, Diabetes Mellitus metabolism, Diabetic Retinopathy genetics, Diabetic Retinopathy therapy, Retinal Degeneration, Nod1 Signaling Adaptor Protein genetics, Nod1 Signaling Adaptor Protein metabolism
- Abstract
Background: Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) plays a pivotal role in inducing metabolic inflammation in diabetes. Additionally, the NOD1 ligand disrupts the equilibrium of bone marrow-derived hematopoietic stem/progenitor cells, a process that has immense significance in the development of diabetic retinopathy (DR). We hypothesized that NOD1 depletion impedes the advancement of DR by resolving bone marrow dysfunction., Methods: We generated NOD1
-/- -Akita double-mutant mice and chimeric mice with hematopoietic-specific NOD1 depletion to study the role of NOD1 in the bone marrow-retina axis., Results: Elevated circulating NOD1 activators were observed in Akita mice after 6 months of diabetes. NOD1 depletion partially restored diabetes-induced structural changes and retinal electrical responses in NOD1-/- -Akita mice. Loss of NOD1 significantly ameliorated the progression of diabetic retinal vascular degeneration, as determined by acellular capillary quantification. The preventive effect of NOD1 depletion on DR is linked to bone marrow phenotype alterations, including a restored HSC pool and a shift in hematopoiesis toward myelopoiesis. We also generated chimeric mice with hematopoietic-specific NOD1 ablation, and the results further indicated that NOD1 had a protective effect against DR. Mechanistically, loss of hematopoietic NOD1 resulted in reduced bone marrow-derived macrophage infiltration and decreased CXCL1 and CXCL2 secretion within the retina, subsequently leading to diminished neutrophil chemoattraction and NETosis., Conclusions: The results of our study unveil, for the first time, the critical role of NOD1 as a trigger for a hematopoietic imbalance toward myelopoiesis and local retinal inflammation, culminating in DR progression. Targeting NOD1 in bone marrow may be a potential strategy for the prevention and treatment of DR., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF